- Question from Jaclin: I would like to know if goserelin is common to use in hormone-receptor-negative breast cancer?
- Answers - Kathy D. Miller, M.D. Goserelin (brand name: Zoladex) works by stopping the ovaries from producing estrogen, so it has only been effective in women with hormone-receptor-positive cancers.
On Wednesday, November 19, 2005, our Ask-the-Expert Online Conference was called Hormone-Receptor-Negative Breast Cancer. Kathy D. Miller, M.D., Marisa Weiss, M.D., and moderator Jennifer Armstrong, M.D. answered your questions about a wide range of issues related to hormone-receptor-negative breast cancer.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.